Member Info for Georgey

Duster - he actually said that he could borrow $500m off RRE's existing assets plus leverage on whatever they acquire so not necessarily much different from previous statements, just expressed in a different way. Of course the debt markets are more difficult so you would expect more conservatism

You also commented yesterday that he said he would wait for the dust to settle before making acquisitions. To be precise, this was a direct response to a question as to whether he would be interested in any publicly listed companies. This is normal as you need to see a share price settle for a while after any significant movement. This does not preclude him from asset deals currently in the market, and he gave plenty of hints he was still on the prowl, although of course these processes and reaching any agreement on valuation are more challenging at the moment

Good evening ShareNicelyNow, do your eps forecasts and share price forecasts go out to y/e 2021 and 20022 when Arran is partially and fully onstream? Thanks

Completion date 1 July (so consolidation for accounting purposes from then). However, economics accrued to RRE from 1 Jan and cashflows 1 Jan - 30 June were reflected in working capital/ cash true-up adjustment at completion

Hannam & Partners unrestricted cash forecasts post capex for end 2019, 2020 and 2021 are $262m, $305m and $494m respectively. Much of 2019 capex of $120m already spent. 2020 capex also 120m.

I think some patience is due. Its only been 5 mins since the last deal and the share price has trebled this year to date. Just with the current asset base equity analysts are forecasting unrestricted cash will hit £70-80 in 3 years. Put whatever margin of error you want on that. And he is in 4-5 data rooms with $300m of cash to put to use, whatever you think about the mooted $1bn firepower. As I've said before he's turned £5m cash and equity value into c.£250m in 3.5 years and there is clear opportunity of generating further multiples, now on a base of £250m. Value will keep building and will be reflected in due course even if always at a discount.

"See what we've done and we'll be doing more of the same". Well Andrew you've turned £5m equity value into £250m in 3.5 years fully underpinned by cash so looking forward to what you'll do with $300m of cash and $1bn firepower. I'll be hanging around.

Zedy - SQZ relisting was driven by Admission Doc release even though completion took 12 months. RRE relisting will be driven by release of Prospectus and RRE have flagged this will be post-closing. Without SQZ US/ Iran links I don't expect anywhere near 12 months but it will be in the months rather than 9-10 days. 1 Jan 19 effective date so cash accumulates while we wait

I will be anticipating a large special divi reflecting excess capital before the end of year

Bought 2x 20000 @ 26.5p this afternoon. Looking forward to the next 12 months or at least the next spike. Good luck all

Fair point levi

See Boil RNS 13th Nov - "No further announcements are planned by Corallian until all the approvals are in place and the drilling has commenced".

You will have to rely on rig traffic tracking and twitter etc for this one. By the time you get an RNS short term money will already have been made

DarryIJ - just about the best LSE post I've ever read. In 3 lines you've encapsulated the magic of patient tax free compounding - an investment classic. Well done on your life-changing investment

Nearly trebled my money on buys at this week's level around the last placing in a short period. History is repeating itself and expect even more upside with a sniff of clinical process and/or a partner related financing. Elartu is also correct. I am surprised they have lasted so long on short term financing needs . Seems that if you ignore significant growth plans and associated financing they are not far off self financing just on the research business.

Thanks for responding Brombarb. I wasn't sure there was something else I had missed.

Hi Brombarb, please could you explain your reference to RBD statements. Thanks

Getting older and more risk averse so took 50% off to put in another one with a scoping study due.

You seem a little too keen to get some negativity out early today Trevor. Bit miffed it takes attention away from FBDU?

I agree it would have been very helpful to know the latest cash position, particularly given the going concern qualifications. Whilst the language is fairly standard it seems to leave open the possibility of further equity issuance - I would be keen to know whether a combination of existing cash, the demo plant start-up and non-core asset sales will cover any near term operating cash outflows and that from early Jan operating cashflow will be positive.

Does anyone have a good grasp of the likely numbers going forward?

Even behind a keyboard, that's some brass neck. Have to laugh

Missed these - thanks. I have been adding this week as I see this moving shortly - the pressure is there. It has been very hard to buy any volume without spiking the price so it has been 100-200k max with the odd 35k and often haven't got any quote at all. But been able to sell anything up to 800k pretty much at any time and even 1m+ time to time. Think we've all learnt that anything bought in 1's will make decent money at some point...

+ seems primary/ priority reason for the share issuing resolution + probably rules out any immediate placing as they would have issued these post placing to max upside + expect good news + at least they weren’t set at zero strike price - shares at 2.8p before AGM notice so they have benefitted as if there were placing. No wonder they included the wording they did. Should have set exercise price at 2.8p - 10% of equity is too much unless they really start delivering so that we all start making money